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~etylglyceryl ether  phosphory lcho l ine  (AGEPC), commonly known as 
~atelet act ivat ing  fac tor ,  was  found to  s t rong ly  inh ib i t  ren in  
~cret ion  in  cu l tu res  r i ch  in  juxtag lomeru lar  ce l l s .  Th is  inh ib i to ry  
~t ion  o f  AGEPC was  accompan ied  by  an  enhanced ca lc ium permeab i l i ty  o f  
~e ce l l  membrane  as  eva luated  f rom measurements  o f  the  uptake  o f  
'Ca .  S imul taneous  add i t ion  o f  the  ca lc ium channe l  b locker  vera - -  
ami l  abo l i shed  the  e f fec ts  o f  AGEPC on  both  ren in  secret ion  and  
a lc ium permeab i l i ty .  Fur thermore ,  add i t ion  o f  AGEPC to  the  ce l l  
a l tu res  led  to  a decrease  o f  asP - labe led  phosphat idy l inos i to l  
,5 - -b i sphosphate  and  to  an  increase  in  3H- - labe led  d iacy lg lycero l ,  
nd icat ing  an  act ivat ion  o f  phospho l ipase  C by  AGEPC. ©1985Acad~icPress, Inc. 
a te le t  ac t ivat ing  fac tor  (PAF)  was  f i r s t  descr ibed  as  an  inductor  o f  
a te le t  aggregat ion  dur ing  IgE -med ia ted  anaphy lax is  in  the  rabb i t  
,2 ) .  PAF has  recent ly  been  ident i f ied  as  1 -0 -a lky l -2 -acety i - sn -g lyce -  
, -3 -phosphory lcho l ine  (AGEPC) (3 ) .  Th is  phosphot ip id  causes  marked  va-  
, const r i c t ion  and  increased  permeab i l i ty  o f  b lood  vesse ls  (4 )  as  we l l  
cont ract ion  o f  i l ea l  smooth  musc le  (57 .  AGEPC i s  p roduced f rom baso-  
i l l s  on immuno log ica l  cha l lenges  and  f rom p la te le ts ,  neut roph i l s  and  
~crophages  in  response  to  spec i f i c  s t imu l i  (6 -11]  and  has  a l so  been 
~monst ra ted  in  the  venous  e f f luent  o f  i so la ted  per fused  ra t  k idney  
I2 )  and  a l so  in  i so la ted  g Iomeru] i  (28) .  Authors  in  (13)  have  shown 
aat  AGEPC possesses  marked  ant ihyper tens ive  ac t iv i ty  when g iven  to  
2o ldbtat t "  one- -k idney ,  one-c l ip  hyper tens ive  ra ts .  Hyper tens ion  in  th i s  
ond i t ion  i s  known to  be  due  to  increased  leve ls  o f  p lasma ren in  w i th  
ubsequent  product ion  o f  ang io tens in  I1 .  In  v iew o f  the  fac t ,  that  AGEPC 
as  vasoconst r i c t ive  proper t ies  and  vasoconst r i c t ive  agents  such  as  
bbrev ia t ions  used;  AGEPC, acety lg [ycery l  e ther  phosphory lcho l ine ;  
AF, p ia te le t  ac t ivat ,  ing  fac tor ' :  A I ,  ang[otens in  I ;  P IPs ,  phospha- -  
idy~nos] lo ]  4 ,5  b i spbosphate ;  DAG, 1 ,2 -d iacy lg lycero i ;  I Pa ,  
nos [ to i t r ' i sphosphate .  
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ang io tens in  I I  and  arg in ine -vasopress in  marked ly  inh ib i t  ren in  secret io r  
(14) ,  i t  i s  tempt ing  to  specu la te  that  the  ant ihyper tens ive  proper t ies  
o f  AGEP¢ in  Go ldb la t t  hyper tens ion  might  be  due  to  a d i rec t  inh ib i t ion  
o f  ren in  secret ion  in  the  k idney .  
Recent ly  we have  es tab l i shed  a ce l l  cu l tu re  sys tem f rom rat  k idneys  
conta in ing  about  60% o f  jux tag lomeru lar  ce l l s  wh ich  a l lows  s tudy  o f  
ren in  secret ion  in  some deta i l .  Aim o f  the  present  s tudy  was to  invest i -  
gate  the  in f luence  o f  AGEPC on ren in  secret ion  as  we l l  as  on some per t i -  
]ent  ce l lu la r  p rocesses  l i ke  ca lc ium permeab i l i ty  o f  the  ce l l  membrane  
~15)  and  phospho inos i t ide  metabo l i sm ( ]6 - -19) .  
~ater ia l s  and  Methods  
i tock  so lu t ions  o f  AGEPC (S igma) ,  ( lO -aM)  in  e thano l  were  prepared  
~nd complexed w i th  0 .3  mg/ml  o f  bov ine  serum a lbumin  (BSA)  in  MEM to  
l i ve  a concent ra t ion  o f  lO -~H.  The  BSA bound AGEPC was  added to  the  
~e l l s  to  g ive  a f ina l  concent ra t ion  o f  lO -aM or  lO -Z°M.  Car r ie r  
' ree  aRP i ,  45Ca and  (aH) -g lycero l  were  f rom Amersham 
:n ternat iona l .  T .L .C .  p la tes  (preeoated  s i l i cage l  60 w i th  concen-  
ra t ion  zone ,  0 ,25  mm th ick )  came f rom Merck ,  Darmstadt ,  F .R .G .  L ip id  
; tandards  and  BSA (essent ia l l y  fa t ty  ac id - f ree)  were  obta ined  f rom 
. igma.  Ce l l  cu l tu re  d i shes  and  ce l l  cu l tu re  med ia  were  f rom Gre iner ,  
[ f i r t ingen ,  F .R .G .  and  Boehr inger -Mannhe im,  respect ive ly .  
e l l  Cu l tures  r i ch  in  juxtag lomeru lar  ce l l s  were  prepared  as  descr ibed  
rev ious ly  (15) .  In  b r ie f ,  ra t  k idneys  were  per fused  in  s i tu  w i th  Hunk 's  
a lanced  sa l t  so lu t ion  supp lemented  w i th  1 g g lucose ,  12 .11  g sucrose ,  
,2g  NaHCO3, 2 .6  mM g lu tamine ,  0 ,84  g Na-c i t ra te  and  [0 mg BSA per  
i te r .  Cor t i ca l  p ieces  (1 mm ~) were  incubated  w i th  th i s  bu f fe r ,con-  
a in ing  0 ,25% t ryps in  and  0 ,1~ co l lagenase  ins tead  o f  Na-c i t ra te .  The  
uspens ion  was  gassed  w i th  5~ C02 in  a i r  and  s t i r red  w i th  a magne-  
i c  bar  a t  37°C.  A f te r  120 m~n.  the  so lu t ion  was poured  over  a 0 ,22  
m s ieve .  Ce l l s  pass ing  the  s ieve  were  washed two t imes  w i th  cu l tu re  
ed ium (RPMI 1640,  25mM Hepes ,  0 ,66  U /ml  insu l in ,  100 gg /ml  s t reptomy-  
in ,  100 U/ml  pen ic i l l i n  and  10% fe ta l  bov ine  serum)  and  seeded in  t i s -  
ue cu l tu re  d i shes  a t  a dens i ty  o f  105 cet ts /cm a .  Cu l tures  were  
ept  a t  37°C in  a humid i f ied  a tmosphere  a t  5% COe in  a i r .  A f te r  
~o days  o f  cu l tu re ,  60% o f  the  adherent  ce l l s  d i sp layed  a s t rong  
nmunoreaet iv i ty  fo r  a spec i f i c  ant ibody  aga ins t  ren in .  The  ren in  con-  
~nt  o f  the  cu l tu red  ce l l s  was  about  l~g  A I /h  x lO ~ ce l l s  a t  that  
[me. 
~term!nat ign . . .o~_~en in  Se£: re t ion .  Ren in  ac t iv i ty  was  determined  by  
:s  ab i l i ty  to  generate  ang io tens in  I (A I )  f rom the  p lasma o f  b i ]a le -  
~ l ly  nephrectomized  ra ts  exact ly  as  descr ibed  in  (20) .  AI was  determl -  
~d by  rad io immunoassay  ( IDW, Dre ie ich ,  F .~.G. )  Ren Jn  secret ion  was  
~vest igated  a t  the  second day  o f  cu l tu re .  The  cu l ture  med ium was subs -  
tu ted  by  a prewarmed buf fe r  cons is t ing  o f  132 mM Nat1 ,  5mM KC1, 0,8mM 
[S04,  2mM CaCle ,  ]OmM Na-aeetate ,  2mM NaHzP04,  lOmM 
ucose ,  20mM hepes  (pH : 7 ,3 )  and  the  cu l ture  d~shes  were  p laced  on a 
.a t ing  b lock  a t  a temperature  of  37~-(:. The  ren in  secret ion  ra te  
s ca lcu la ted  f rom the  l inear  inc rease  o f  the  ren ln  ac t iv i ty  o£ the  
l ] - cond i t ioned  buf fe r .  
~g~O~_~_~gfg~z~P~9~.  The  cutLure  medium was  subst i  
ted  by  a prewarmed Hepes  but fe red  sa l ine  ~HBS) cons is t ing  o f  20mM He-- 
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pes, 148mM NaCl, 5mM KCI, 2mM CaCl2, lmM Mgc'i2, 6mM Glucose, 
pH 7,3 supplemented with 45Ca (4g Ci/ml). S imultaneously,  AGEPC 
or verapamil  or a combinat ion of both was added. At di f ferent times, 
buffer  was wi thdrawn and the cells quickly washed with lO x 1 ml 
ice-cold HBS conta in ing lOmM CaCl~. The cel ls were lysed by the 
addit ion of 1 ml of 0,5N NaOH and the rad ioact iv i ty  was counted in I0 ml 
Aquasol 2 (New England Nuclear) in a ~-sc int i l lat ion counter. 
two days  o f  cu l tu re ,  medium was removed and the  ce l l s  were  incubated  
fo r  24 hours  in  phosphate -poor  MEM (50~M P~) conta in ing  
100gCi /ml  z~Pi  o r  w i th  MEM conta in ing  5~Ci /ml  ( zH) -  
g lycero l .  A f te r  th i s  p re labe l ing  per iod  the  medium was rep laced  by 
f resh  medium e i ther  w i thout  (cont ro l )  o r  w i th  AGEPC (10-SM) .  
and Diac~!g lycer9 ~. Incubat ions Were terminated by addit ion of ice-cold 
methanol -ch loroform,  and l ipid extract ion was done as descr ibed (21). 
The extracted 32p- labe led phosphol ip ids  were separated on thin- 
layer plates impregnated with potass ium oxalate and EDTA with a solvent 
system cons ist ing of ch loro form/methano l /4N NH40H (45/35/I0, by 
vol.) Neutral  l ipids were separated using n-heptane/  diethyl ether/ace-  
tic acid (75/25/4, by vol.) as descr ibed (21). Phosphol ip ids  and neutral  
l ipids were local ized by comigrat ion of standards fo l lowed by iodine 
staining and 32P- labe l led  lipids addi t iona l ly  by autoradiography.  
The spots were scraped from the chromatographs and counted by l iquid 
sc int i l la t ion in water  (Cerenkov counting) for 32p label led lipids. 
(3H)- labeled l ipids were analysed with a TLC- l inear  analyzer LB 
2821 from Berthold, Mfinchen, F.R.G. The detect ion ef f ic iency for 
(~H) was about 1%. Protein determinat ion was done accord ing to the 
method of Lowry (22) with BSA as standard. 
Resu l ts  
F ig .  1 shows that  AGEPC s t rong ly  inh ib i ted  the  spontaneous  ren in  secre -  
t ion  in  a concent ra t ion  dependent  manner .  Wh i l s t  in  cont ro l  exper iments ,  
the  ra te  o f  ren in  secret ion  was about  390 pg A:[/h per  min per  d i sh ,  
AGEPC at  concent ra t ions  o f  (10- iOM)  and (10-SM) reduced  the  
secret ion  ra te  to  175 pg A I /h  and to  72 .5  pg A I /h  per  min .  and d i sh  
respect ive ly .  Note ,  that  the  te rm A I /h  i s  fo rmal ly  equ iva lent  w i th  one 
un i t  o f  ren in  ac t iv i ty .  Th is  inh ib i t ion  cou ld  on ly  be observed  dur ing  
the  f i r s t  15 minutes  and reached cont ro l  l eve ls  a f te r  60 minutes .  S imu l -  
taneous  add i t ion  o f  verapami ]  (10-~M) complete ly  abo l i shed  the  
inh ib i to ry  e f fec t  o f  AGEPC, wh i l s t  the  add i t ion  o f  verapami l  a lone  
great ly  enhanced  ren in  secret ion  (F ig .  1 ) .  
F ig .  2 shows that  ca lc ium uptake  by the  cu l tu red  ce l l s  was inc reased  
in  the  presence  o f  AGEPC (10-SM) .  Yerapami l  (10-~M) 
s t r0ng]y  reduced  the  ca lc ium uptake  and the  s imu l taneous  add i t ion  o f  
AGEPC and verapami l  a l so  reduced  the  ca lc ium uptake ,  but  to  a s t ighter  
[ 
degree  than  d id  verapami l  a lone .  
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Ren in  secret ion  ra te  o f  cu l tu red  juxtag lomeru la r  ce l l s  in  
the  presence  o f  acety lg lyeery ]  e ther  phosphory lcho l ine  
(AGEPC) (lO-SM) and (lO-1°M), verapamil  (VP) 
• (10-SM) and the combinat ion of AGEPC (10-SM) 
and VP (lO-SM). Data are mean +/- S.E.M. Figures 
at the bottom of the columns indicate the number of 
independent experiments. 
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4SCa lc ium uptake  in  the  presence  o f  AGEPC 
( IO-SM) ,  verapami l  ( lO -SM)  and  a f te r  
s imu l taneous  add i t ion  o f  AGEPC ( lO -SM)  and  verapami l  
( lO -SM) .  Resu l t s  a re  presented  as  mean ÷/ -  S .E .M.  o f  
e ight  exper iments .  
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F ig .  3 T ime course  o f  azp  rad ioact iv i ty  in  phosphat idy l -  
inositol 4,5-bisphosphate. Open symbols represent 
stimulation with AGEPC (lO-aM); filled symbols 
represent control values. Values are mean +/- S.E.M., 
n -- 5. 
litton of AGEPC ( IO-BM) to the cel ls  p rovoked a rap id  decrease  of 
P) rad ioact iv i ty  found in phosphat idy l inos i to l  4 ,5 -b i sphosphate  
[P~) (Fig. 3). This ef fect  could be detected  as ear ly  as 10 se- 
ida after  add i t ion  or AGEPC and was max imal  (60% of cont ro l ) 'w i th in  20 
One minute  after  add i t ion  of AGEPC, the level of 32p in PIPe 
zreased and approached cont ro l  levels, fo l towed by an increase  above 
it ial  levels at 2 minutes.  This ear ly  decrease  of s~P- labe l  in 
P2 was fo l lowed by a subsequent  increase  of (3H)-g lyce-  
1-1abel  in d iacy lg lycero l  DAG) wh ich  had a max imum 30 s af ter  addi-  
on of AGEPC (Fig. 4). 
seuss ion  
e s t rong inh ib i t ion  of renln secret ion  by AGEPC (Fig. I) is comparab le  
that of  other  vasoconst r i c t ive  agents  l ike ang io tens in  II and arg in i -  
-vasopress in  {14). In ana logy  to what we have recent ly  shown for 
g io tens in  II, AGEPC inh ib i ts  renin secret ion  probab ly  by enhanc ing  the 
: permeab~ [ity of the ceil membrane,  thereby increas ing  the in t race[ lu -  
[r ca lc ium concent ra t ions  (15). The complete  suppress ion  by verapami l  
" the act ion  of AGEPC on renin secret ion  suggests  that AGEPC acts by 
,ening ca lc ium channels .  The fact that an inh ib i t ion  of renin secret ion  
,u[d be observed  only dur inK  the f i rst  15 min. a f ter  add i t ion  of AGEPC 
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Time course  o f  (3H)g lycero l  rad ioact iv i ty  in  
1,2 -d iacy lg lycero l  in  jux tag lomeru lar  ce l l s  
s t imu la ted  w i th  AGEPC ( lO-SM) ;  open  symbols  
represent  s t imu la t ion  w i th  AGEPC ( lO-S) ;  
f i l l ed  symbo ls  represent  cont ro l  va lues .  
s very  l i ke ly  to  be  due  to  the  fas t  degradat ion  o f  the  agent  (23) .  
t now appears  to  be  genera l ly  accepted  that  hormones  and  neurot ransmi t -  
e rs  that  use  ca lc ium as  second messenger  spec i f i ca l ly  hydro lyse  membra-  
e phospho inos i t ides .  M iche l1  suggested  in  1975 that  ca lc ium mobi l J za -  
ion  i s  l inked  to  phosphat idy l inos i to l  b reakdown (24) .  However ,  more  
ecent  exper iments  have  demonst ra ted  that  the  pr imary  event  in  receptor  
t imu la ted  inos i to l  phospho l ip id  metabo l i sm i s  by  an  act ion  o f  
hospho l ipase  C (PLC)  upon phosphat idy l inos i to l  4 ,5 -b i sphosphate  
P IP2)  ( fo r  rev iew see  25-26) .  S ince  AGEPC i s  known to  cause  
IPz  degradat ion  in  p la te le ts  (17- -19)  and  hepatocytes  (16) ,  we have  
~amined the  e f tec t  o f  AGEPC on P IP2  metabo l i sm in  our  ce l l  cu l tu re  
rs tem.  The  resu l t s  p resented  in  F igs .  3 and  4 c lear ly  show that  AGEPC 
~ads  to  a loss  o f  rad ioact iv i ty  f rom P IP2  and  an  increase  o f  
H) -g ]ycero l  labe l  in  d iacy lg ]ycero l  (DAG) .  There fore ,  AGEPC 
,parent ly  s t imu la tes  PLC in  our  ce l l  cu l tu re  sys tem.  We have  observed  
~ry s imi la r  e f fec ts  o f  ang io tens in  I I  and  arg in ine -vasopress in  on  the  
Los i to l  phospho l ip id  metabo l i sm in  these  ce l l s  (manuscr ip t  submi t ted) .  
, th  o f  the  c leavage products  o f  P IP2  metabo l i sm,  i .e .  DAG and 
os i to l  1 ,4 ,5 - t r i sphosphate  IP3)  a re  impor tant  second messengers  
o r  rev iew see  (27) ) .  IP3 i s  thought  to  be  the  in t race l lu ]ar  s ig -  
1 to  promote  hormone induced ca lc ium mobi l i za t ion  and  DAG act ivates  
o te in  k inase  C wh ich  in  tu rn  phosphory la tes  var ious  ce l lu la r  p ro te ins .  
have  recent ly  found that  the  phorbo]  es ter ,  ]2 -O- te t radecanoy] - -  
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bol-13-acetate,  which is widely used as an act ivator  of protein ki- 
C, enhances the calc ium permeabi l i ty  in cultured glomerular  mesan- 
cells (unpubl ished results). In view of this, it can be speculated 
an act ivat ion of protein kinase C by DAG is causal ly  related to the 
ease in calc ium permeabi l i ty  observed in the present exper iments 
. 2). 
:his report we have presented evidence, that AGEPC strongly inf luen- 
renin secret ion and phospho inos i t ide  metabol ism in cultures rich in 
~l juxtag lomeru lar  cells. The low concentrat ion at which AGEPC inhi- 
3 renin secret ion (lO-Z°M) and also the fact that AGEPC is pro- 
ed by the kidney itself  (12, 28) supports the not ion that AGEPC is 
o]ved in the regulat ion of k idney renin secret ion and may be part 
an intrarenal  feedback mechanism contro l l ing renin secretion. 
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